| Study period | |||
---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close out | |
-12h to 0 | 0 | 24h | 48h | |
Enrolment | ||||
 Eligibility screen | X |  |  |  |
 Informed consent | X |  |  |  |
 Standard analgesic procedure | X | X | X | X |
 Allocation |  | X |  |  |
Interventions | ||||
 Acetaminophen 1g/100ml Q6H IV |  | X | X | X |
 Saline 100ml Q6H IV |  | X | X | X |
Assessments | ||||
 Demographic data | X |  |  |  |
 MDAS | X |  | X | X |
 Type and location of pain | X |  |  |  |
 VNRS | X |  | X | X |
 VAS | X |  | X | X |
 MEDD | X |  | X | X |
 Drug use in the past 24 h (corticosteroids, NSAIDs) | X |  | X | X |
 Cancer treatments received | X |  |  |  |
 Karnofsky score | X |  |  |  |
 CAGE-AID | X |  |  |  |
 ESAS-SF | X |  |  | X |
 HADS | X |  |  | X |
 EORTC QLQ-C15-PAL | X |  |  |  |
 Comorbidities | X |  |  |  |
 Side effects | X |  | X | X |
 Patient perception of pain improvement |  |  | X | X |
 MCID |  |  | X | X |